Stigmatisation and body image impairment in dermatological patients

protocol for an observational multicentre study in 16 European countries

Florence J Dalgard, Anthony Bewley, Andrea W Evers, Uwe Gieler, Lars Lien, Francesca Sampogna, Sonja Ständer, Lucia Tomas-Aragones, Ninke Vulink, Jörg Kupfer

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Patients with common skin diseases may have substantial psychosocial comorbidity and reduced quality of life. This study aims at exploring further the psychosocial burden of skin diseases by assessing stigmatisation and body image problems in a large sample of patients with skin disease across Europe.

METHODS AND ANALYSIS: The study is an observational cross-sectional multicentre study across 16 European countries comparing stigmatisation and body image in patients with skin disease compared with controls. Consecutive patients will be recruited in outpatient clinics and will complete validated questionnaires prior to clinical examination by a dermatologist at each recruitment site. In addition to sociodemographic background information, the outcomes will be: mood disorders assessed by short versions of the Patient Health Questionnaire and the General Anxiety Disorder Assessment; general health assessed by the EuroQol-Visual Analogue Scale; stigmatisation experience assessed by the Perceived Stigmatisation Questionnaire; stress assessed by the Perceived Stress Scale and body image assessed by the Dysmorphic Concern Questionnaire. The main criteria for eligibility are to be 18 years old or more. The analysis will include comparison between patients and controls for the main outcomes using t-tests, analyses of covariance and multivariate logistic regression models adjusting for potential confounding factors.

ETHICS AND DISSEMINATION: The study protocol is approved by the University of Giessen and by the local Ethical Committee in each recruitment centre. Informed consent will be given by each participant. The results of the study will be disseminated by publications in international peer-reviewed journals and presented at international conferences and general public conferences. Results will influence support intervention and management of patients with skin disease across Europe.

TRIAL REGISTRATION NUMBER: DRKS00012745; Pre-results.

Original languageEnglish
Pages (from-to)e024877
JournalBMJ Open
Volume8
Issue number12
DOIs
Publication statusPublished - Dec 22 2018

Fingerprint

Stereotyping
Body Image
Multicenter Studies
Observational Studies
Skin Diseases
Logistic Models
Health
Ambulatory Care Facilities
Anxiety Disorders
Informed Consent
Mood Disorders
Visual Analog Scale
Publications
Comorbidity
Multivariate Analysis
Cross-Sectional Studies
Quality of Life
Surveys and Questionnaires

Cite this

Stigmatisation and body image impairment in dermatological patients : protocol for an observational multicentre study in 16 European countries. / Dalgard, Florence J; Bewley, Anthony; Evers, Andrea W; Gieler, Uwe; Lien, Lars; Sampogna, Francesca; Ständer, Sonja; Tomas-Aragones, Lucia; Vulink, Ninke; Kupfer, Jörg.

In: BMJ Open, Vol. 8, No. 12, 22.12.2018, p. e024877.

Research output: Contribution to journalArticle

Dalgard, FJ, Bewley, A, Evers, AW, Gieler, U, Lien, L, Sampogna, F, Ständer, S, Tomas-Aragones, L, Vulink, N & Kupfer, J 2018, 'Stigmatisation and body image impairment in dermatological patients: protocol for an observational multicentre study in 16 European countries', BMJ Open, vol. 8, no. 12, pp. e024877. https://doi.org/10.1136/bmjopen-2018-024877
Dalgard, Florence J ; Bewley, Anthony ; Evers, Andrea W ; Gieler, Uwe ; Lien, Lars ; Sampogna, Francesca ; Ständer, Sonja ; Tomas-Aragones, Lucia ; Vulink, Ninke ; Kupfer, Jörg. / Stigmatisation and body image impairment in dermatological patients : protocol for an observational multicentre study in 16 European countries. In: BMJ Open. 2018 ; Vol. 8, No. 12. pp. e024877.
@article{3451fa09c8724d4895e5eae8771465b8,
title = "Stigmatisation and body image impairment in dermatological patients: protocol for an observational multicentre study in 16 European countries",
abstract = "INTRODUCTION: Patients with common skin diseases may have substantial psychosocial comorbidity and reduced quality of life. This study aims at exploring further the psychosocial burden of skin diseases by assessing stigmatisation and body image problems in a large sample of patients with skin disease across Europe.METHODS AND ANALYSIS: The study is an observational cross-sectional multicentre study across 16 European countries comparing stigmatisation and body image in patients with skin disease compared with controls. Consecutive patients will be recruited in outpatient clinics and will complete validated questionnaires prior to clinical examination by a dermatologist at each recruitment site. In addition to sociodemographic background information, the outcomes will be: mood disorders assessed by short versions of the Patient Health Questionnaire and the General Anxiety Disorder Assessment; general health assessed by the EuroQol-Visual Analogue Scale; stigmatisation experience assessed by the Perceived Stigmatisation Questionnaire; stress assessed by the Perceived Stress Scale and body image assessed by the Dysmorphic Concern Questionnaire. The main criteria for eligibility are to be 18 years old or more. The analysis will include comparison between patients and controls for the main outcomes using t-tests, analyses of covariance and multivariate logistic regression models adjusting for potential confounding factors.ETHICS AND DISSEMINATION: The study protocol is approved by the University of Giessen and by the local Ethical Committee in each recruitment centre. Informed consent will be given by each participant. The results of the study will be disseminated by publications in international peer-reviewed journals and presented at international conferences and general public conferences. Results will influence support intervention and management of patients with skin disease across Europe.TRIAL REGISTRATION NUMBER: DRKS00012745; Pre-results.",
author = "Dalgard, {Florence J} and Anthony Bewley and Evers, {Andrea W} and Uwe Gieler and Lars Lien and Francesca Sampogna and Sonja St{\"a}nder and Lucia Tomas-Aragones and Ninke Vulink and J{\"o}rg Kupfer",
note = "{\circledC} Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2018",
month = "12",
day = "22",
doi = "10.1136/bmjopen-2018-024877",
language = "English",
volume = "8",
pages = "e024877",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - Stigmatisation and body image impairment in dermatological patients

T2 - protocol for an observational multicentre study in 16 European countries

AU - Dalgard, Florence J

AU - Bewley, Anthony

AU - Evers, Andrea W

AU - Gieler, Uwe

AU - Lien, Lars

AU - Sampogna, Francesca

AU - Ständer, Sonja

AU - Tomas-Aragones, Lucia

AU - Vulink, Ninke

AU - Kupfer, Jörg

N1 - © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2018/12/22

Y1 - 2018/12/22

N2 - INTRODUCTION: Patients with common skin diseases may have substantial psychosocial comorbidity and reduced quality of life. This study aims at exploring further the psychosocial burden of skin diseases by assessing stigmatisation and body image problems in a large sample of patients with skin disease across Europe.METHODS AND ANALYSIS: The study is an observational cross-sectional multicentre study across 16 European countries comparing stigmatisation and body image in patients with skin disease compared with controls. Consecutive patients will be recruited in outpatient clinics and will complete validated questionnaires prior to clinical examination by a dermatologist at each recruitment site. In addition to sociodemographic background information, the outcomes will be: mood disorders assessed by short versions of the Patient Health Questionnaire and the General Anxiety Disorder Assessment; general health assessed by the EuroQol-Visual Analogue Scale; stigmatisation experience assessed by the Perceived Stigmatisation Questionnaire; stress assessed by the Perceived Stress Scale and body image assessed by the Dysmorphic Concern Questionnaire. The main criteria for eligibility are to be 18 years old or more. The analysis will include comparison between patients and controls for the main outcomes using t-tests, analyses of covariance and multivariate logistic regression models adjusting for potential confounding factors.ETHICS AND DISSEMINATION: The study protocol is approved by the University of Giessen and by the local Ethical Committee in each recruitment centre. Informed consent will be given by each participant. The results of the study will be disseminated by publications in international peer-reviewed journals and presented at international conferences and general public conferences. Results will influence support intervention and management of patients with skin disease across Europe.TRIAL REGISTRATION NUMBER: DRKS00012745; Pre-results.

AB - INTRODUCTION: Patients with common skin diseases may have substantial psychosocial comorbidity and reduced quality of life. This study aims at exploring further the psychosocial burden of skin diseases by assessing stigmatisation and body image problems in a large sample of patients with skin disease across Europe.METHODS AND ANALYSIS: The study is an observational cross-sectional multicentre study across 16 European countries comparing stigmatisation and body image in patients with skin disease compared with controls. Consecutive patients will be recruited in outpatient clinics and will complete validated questionnaires prior to clinical examination by a dermatologist at each recruitment site. In addition to sociodemographic background information, the outcomes will be: mood disorders assessed by short versions of the Patient Health Questionnaire and the General Anxiety Disorder Assessment; general health assessed by the EuroQol-Visual Analogue Scale; stigmatisation experience assessed by the Perceived Stigmatisation Questionnaire; stress assessed by the Perceived Stress Scale and body image assessed by the Dysmorphic Concern Questionnaire. The main criteria for eligibility are to be 18 years old or more. The analysis will include comparison between patients and controls for the main outcomes using t-tests, analyses of covariance and multivariate logistic regression models adjusting for potential confounding factors.ETHICS AND DISSEMINATION: The study protocol is approved by the University of Giessen and by the local Ethical Committee in each recruitment centre. Informed consent will be given by each participant. The results of the study will be disseminated by publications in international peer-reviewed journals and presented at international conferences and general public conferences. Results will influence support intervention and management of patients with skin disease across Europe.TRIAL REGISTRATION NUMBER: DRKS00012745; Pre-results.

U2 - 10.1136/bmjopen-2018-024877

DO - 10.1136/bmjopen-2018-024877

M3 - Article

VL - 8

SP - e024877

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 12

ER -